<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04681547</url>
  </required_header>
  <id_info>
    <org_study_id>HCB/2019/1148</org_study_id>
    <secondary_id>2019-005010-19</secondary_id>
    <nct_id>NCT04681547</nct_id>
  </id_info>
  <brief_title>Ultrasound-guided Genicular Nerve Block for Total Knee Arthroplasty.</brief_title>
  <acronym>PGENECA</acronym>
  <official_title>Ultrasound-guided Genicular Nerve Block: An Analgesic Alternative to LIA for Total Knee Arthroplasty.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Clinic of Barcelona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis is to demonstrate the analgesic non-inferiority of the ultrasound-guided&#xD;
      geniculate nerve block when compared to the local infiltration analgesia (LIA). It is&#xD;
      expected to maintain the quality of analgesia with a selective blockade of the nerves&#xD;
      responsible for the sensitive innervation of the knee, reducing the total dose of local&#xD;
      anesthetic and adrenaline very markedly.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective is to demonstrate that the ultrasound-guided geniculate nerve block&#xD;
      provides not-inferior analgesia to LIA in patients undergoing primary total knee arthroplasty&#xD;
      (TKA) in the first 24 hours postoperatively, and during the first mobilization using the&#xD;
      numerical evaluation of the pain (NRS).&#xD;
&#xD;
      The secondary objectives are to demonstrate that the consumption of opioids and the range of&#xD;
      joint mobility are not inferior in those patients who receive geniculate nerve blocks&#xD;
      compared to those who receive LIA.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 15, 2020</start_date>
  <completion_date type="Actual">April 30, 2021</completion_date>
  <primary_completion_date type="Actual">April 30, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>NRS at PACU</measure>
    <time_frame>1 hour after surgery</time_frame>
    <description>NRS [Numerical Rating Scale, 0-11] at PACU [post-anaesthesia care unit] after spinal block reversal, evaluated as active contralateral knee genuflection at 90 degrees.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>NRS at 12 hours after surgery</measure>
    <time_frame>12 hours</time_frame>
    <description>Pain will be assessed by NRS [Numerical Rating Scale, 0-11] by a ward nurse, blind for intraoperative analgesic treatment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>NRS at 24 hours after surgery</measure>
    <time_frame>24 hours</time_frame>
    <description>Pain will be assessed by NRS [Numerical Rating Scale, 0-11] by a ward nurse, blind for intraoperative analgesic treatment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>NRS after physiotherapy</measure>
    <time_frame>24 hours</time_frame>
    <description>It corresponds to day 1 after the surgical intervention and will be carried out in the hospitalization room by a physiotherapist. The NRS [Numerical Rating Scale, 0-11] will be recorded during the first examination and mobilization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption in the postoperative period</measure>
    <time_frame>until 24 hours</time_frame>
    <description>Opioid consumption in the postoperative period in oral morphine equivalents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee mobility range</measure>
    <time_frame>24 hours</time_frame>
    <description>Minimal and maximal mobility range [degrees]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of sleep</measure>
    <time_frame>24 hours</time_frame>
    <description>Quality of sleep of the first night using the quality of sleep visual analogue scale [0-100 mm]</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Genicular nerve block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An ultrasound-assisted genicular nerve block will be performed. 4 ml of 0.2% ropivacaine will be administered, with adrenaline 1: 100 000 in each of the five nerves.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local infiltration Analgesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of ropivacaine 0.2% 150 ml will be performed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Genicular nerve Block</intervention_name>
    <description>After the administration of spinal anesthesia, the anatomical structures of the proximal and distal region of the knee will be explored through an M- ultrasound machine Turbo® with a high-frequency 6-13 MHz linear probe.&#xD;
The ultrasound transducer will be placed in a coronal orientation to the axis of the knee in the corresponding area to be blocked according to anatomical landmarks of superior medial genicular nerve (SMGN), inferior medial genicular nerve block (IMGN), superior lateral genicular nerve (SLGN), inferior lateral genicular nerve (ILGN), and recurrent genicular nerve (RGN).&#xD;
It should be noted that the visualization of the genicular arteries in the femoral epicondyles and in the area of the tibial plateau, represents an accurate guide to where the sensory afferents are, however; its display is not constant.&#xD;
4 ml of 0.2% ropivacaine will be administered, with adrenaline 1: 100 000 in each of the five nerves.</description>
    <arm_group_label>Genicular nerve block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Local Infiltration Analgesia</intervention_name>
    <description>100 ml of ropivacaine 0.2% with 1 mg of epinephrine during the period of intraoperative ischemia and, before the closure of the surgical wound, 50 ml of ropivacaine 0.2%.</description>
    <arm_group_label>Local infiltration Analgesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects scheduled for primary elective total knee arthroplasty&#xD;
&#xD;
          -  American Society of Anesthesiologists Physical Status I-III&#xD;
&#xD;
          -  BMI 18-40 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to cooperate with protocol&#xD;
&#xD;
          -  Allergy to any medication of protocol&#xD;
&#xD;
          -  Contraindication to peripheral nerve block (e.g. local or systemic infection,&#xD;
             neurologic deficit or disorder, previous trauma or surgery to ipsilateral knee, etc.)&#xD;
&#xD;
          -  Revision or prothesis replacement knee surgery&#xD;
&#xD;
          -  Chronic opioid consumption (daily morphine equivalent of &gt;30 mg for at least four&#xD;
             weeks prior to surgery)&#xD;
&#xD;
          -  Bleeding diathesis or non-pharmacological coagulopathy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tomás López, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clinic of Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xavier Sala-Blanch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clinic of Barcelona</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Clínic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>December 15, 2020</study_first_submitted>
  <study_first_submitted_qc>December 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 23, 2020</study_first_posted>
  <last_update_submitted>May 31, 2021</last_update_submitted>
  <last_update_submitted_qc>May 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Clinic of Barcelona</investigator_affiliation>
    <investigator_full_name>TOMAS MIGUEL CUÑAT LOPEZ</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Analgesia</keyword>
  <keyword>LIA</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Genicular Nerve Block</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

